Si Shi Selected Research

Si Shi Research Topics

Disease

55	Neoplasms (Cancer) 01/2022 - 04/2012
46	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 04/2012
16	Adenocarcinoma 01/2022 - 06/2016
16	Neoplasm Metastasis (Metastasis) 12/2021 - 08/2012
9	Carcinogenesis 01/2022 - 09/2016
8	Nasopharyngeal Carcinoma 09/2021 - 12/2015
5	COVID-19 11/2022 - 11/2020
4	Carcinoma (Carcinomatosis) 01/2018 - 08/2015
3	Inflammation (Inflammations) 05/2022 - 02/2017
3	Ischemia 05/2022 - 01/2017
3	Hypoxia (Hypoxemia) 08/2020 - 10/2015
3	Pain (Aches) 01/2020 - 04/2016
2	Reperfusion Injury 05/2022 - 01/2019
2	Myocardial Ischemia (Ischemic Heart Diseases) 05/2022 - 09/2020
2	Cognitive Dysfunction 01/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2016
2	Lymphatic Metastasis 01/2021 - 03/2013
2	Acute Kidney Injury (Acute Renal Failure) 09/2020 - 01/2019
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2020 - 11/2015
2	Emergence Delirium 01/2020 - 02/2018
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 12/2019 - 12/2019
2	Margins of Excision 11/2019 - 01/2019
2	Starvation 12/2018 - 01/2015
2	Lymphoma (Lymphomas) 01/2018 - 05/2017
2	Disease Progression 01/2018 - 05/2015
2	Hyperglycemia 02/2017 - 04/2016
1	Infections 11/2022
1	Human Influenza (Influenza) 11/2022
1	Cardiomegaly (Heart Hypertrophy) 08/2022
1	Infarction (Infarctions) 05/2022
1	Memory Disorders (Memory Loss) 01/2022
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022
1	Infectious Arthritis (Septic Arthritis) 01/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2014
14	Gemcitabine FDA Link 01/2022 - 04/2012
13	Biological ProductsIBA 01/2022 - 08/2012
12	Biomarkers (Surrogate Marker)IBA 04/2021 - 04/2016
5	Messenger RNA (mRNA)IBA 01/2022 - 08/2015
4	Interleukin-6 (Interleukin 6)IBA 11/2022 - 01/2020
4	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2020
4	Immune Checkpoint InhibitorsIBA 01/2022 - 12/2019
4	Glucose (Dextrose)FDA LinkGeneric 07/2021 - 01/2016
4	130-nm albumin-bound paclitaxelIBA 05/2021 - 01/2019
4	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2012
3	Pharmaceutical PreparationsIBA 01/2022 - 04/2012
3	folfirinoxIBA 05/2021 - 04/2012
3	Dexmedetomidine FDA Link 09/2020 - 02/2018
3	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2015
3	CarbohydratesIBA 01/2019 - 05/2015
2	CytokinesIBA 11/2022 - 10/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2022 - 11/2020
2	VaccinesIBA 03/2022 - 01/2022
2	N-methyladenosineIBA 01/2022 - 01/2020
2	AntioxidantsIBA 01/2022 - 04/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 12/2019
2	Neuroprotective AgentsIBA 01/2022 - 02/2018
2	AlbuminsIBA 01/2022 - 11/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 01/2022 - 01/2021
2	SilverIBA 01/2022 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 10/2021
2	Long Noncoding RNAIBA 01/2022 - 09/2016
2	ChemokinesIBA 10/2021 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 10/2015
2	LipidsIBA 07/2021 - 01/2018
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2018
2	Circular RNAIBA 01/2021 - 01/2021
2	Cadherins (E-Cadherin)IBA 01/2020 - 04/2016
2	EnzymesIBA 01/2020 - 05/2015
2	Chloroquine (Aralen)FDA LinkGeneric 01/2020 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 01/2018
2	AntigensIBA 01/2019 - 01/2017
2	Malondialdehyde (Propanedial)IBA 01/2018 - 01/2017
2	Matrix Metalloproteinase 13IBA 01/2018 - 12/2015
2	Oxygen (Dioxygen)IBA 01/2018 - 12/2016
2	ThioredoxinsIBA 10/2017 - 01/2016
2	DisintegrinsIBA 03/2017 - 11/2015
2	Metalloproteases (Metalloproteinases)IBA 03/2017 - 11/2015
2	Tumor Biomarkers (Tumor Markers)IBA 01/2017 - 05/2015
2	GTP Phosphohydrolases (GTPases)IBA 01/2017 - 06/2016
2	Oncogene Proteins (Oncogene Protein)IBA 01/2016 - 05/2015
1	Antiviral Agents (Antivirals)IBA 11/2022
1	Oseltamivir (Tamiflu)FDA Link 11/2022
1	antineoplaston A10 (A 10)IBA 11/2022
1	baloxavirIBA 11/2022
1	isoliquiritigenin (GU 17)IBA 08/2022
1	maslinic acidIBA 05/2022
1	MB Form Creatine KinaseIBA 05/2022
1	Inactivated VaccinesIBA 03/2022
1	Sorafenib (BAY 43-9006)FDA Link 01/2022
1	IronIBA 01/2022

Therapy/Procedure

21	Therapeutics 11/2022 - 04/2012
15	Drug Therapy (Chemotherapy) 01/2022 - 04/2012
6	Immunotherapy 01/2022 - 12/2019
5	Neoadjuvant Therapy 05/2021 - 12/2019
4	Adjuvant Chemotherapy 01/2021 - 01/2018
3	Pancreatectomy 12/2021 - 12/2019
2	Radiotherapy 08/2020 - 01/2018
1	Intramuscular Injections 01/2022